Aptuit appoints Jonathan Goldman CEO
This article was originally published in Scrip
Early to mid-phase drug development service provider Aptuit has named Dr Johnathan Goldman chief executive officer. Dr Goldman joins the Greenwich, Connecticut-based company from contract research firm ICON, where he was executive vice-president of global strategic and business development. Dr Goldman is also an associate clinical professor of medicine in the division of cardiology at the University of California.